CA50785-6B - 0x0000000000006BF0

Healthy Males & Females

Forward

* Stipend may pay up to reflected amount.
Start Date: 
October 22, 2026 - 2:45pm
End Date: 
October 30, 2026 - 9:15am

Study Details

Study Number: CA50785
Group Number: 6B
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,250.00

Study Criteria

Age: 19 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed for the treatment of multiple sclerosis (MS).
Route of Administration: Oral
Blood Draws: 16

Study Schedule

Schedule Type:
Study Length: 3 Night Stay & 2 Returns

Screening Dates:

Event Day Event Date
Thursday 10/8/2026
Friday 10/9/2026
Monday 10/12/2026
Wednesday 10/14/2026
Thursday 10/15/2026

Doctor Exam Dates:

Event Day Event Date
Thursday 10/8/2026
Friday 10/9/2026
Monday 10/12/2026
Wednesday 10/14/2026
Thursday 10/15/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Thursday 10/22/2026 2:45:00 PM Sunday 10/25/2026 9:15:00 AM 1 Lincoln
Return Tuesday 10/27/2026 8:15:00 AM Tuesday 10/27/2026 9:15:00 AM 1 Lincoln
Return Friday 10/30/2026 8:15:00 AM Friday 10/30/2026 9:15:00 AM 1 Lincoln